Previous 10 | Next 10 |
home / stock / nriff / nriff news
MISSISSAUGA, Ontario, March 23, 2020 (GLOBE NEWSWIRE) -- Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Nuvo’s President ...
Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx™ For The Acute Treatment of Migraine Canada NewsWire MISSISSAUGA, ON, Feb. 27, 2020 - Canadian Launch Anticipated in the Second Half of 2020 - MISSISSAUGA, ON , Feb. 27, 2020 /CNW/ - Nuvo Pharm...
Nuvo Pharmaceuticals Inc. (NRIFF) Q4 2019 Earnings Conference Call February 25, 2020, 08:30 AM ET Company Participants Jesse Ledger - President and CEO Mary-Jane Burkett - VP and CFO Tina Loucaides - VP, Secretary and General Counsel Conference Call Participants David Marti...
٠ Fiscal Year 2019 Adjusted Total Revenue - $74.7 million ٠ ٠ Fiscal Year 2019 Adjusted EBITDA - $27.2 million ٠ ٠ Blexten Canadian Prescriptions Increased 61% Year-Over-Year ٠ ٠ Cambia Cana...
Nuvo Pharmaceuticals™ Responds to Market Activity Canada NewsWire MISSISSAUGA, ON, Feb. 11, 2020 MISSISSAUGA, ON , Feb. 11, 2020 /CNW/ - At the request of the Investment Industry Regulatory Organization of Canada (IIROC), Nuvo Pharmaceuticals Inc. (Nuvo or t...
Nuvo Pharmaceuticals™ Announces Fourth Quarter 2019 Results Release Date and Conference Call Details Canada NewsWire MISSISSAUGA, ON, Feb. 11, 2020 MISSISSAUGA, ON , Feb. 11, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Can...
MISSISSAUGA, ON , Jan. 7, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced the Company will repay its Bridge Loan to Deerf...
VIMOVO Litigation to Continue MISSISSAUGA, ON , Nov. 11, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced that the Un...
Nuvo Pharmaceuticals Inc. (NRIFF) Q3 2019 Earnings Conference Call October 31, 2019 08:30 ET Company Participants Jesse Ledger - President and Chief Executive Officer Mary-Jane Burkett - Vice President and Chief Financial Officer Tina Loucaides - Vice President, Secretary and Gen...
Nuvo Pharmaceuticals™ Announces 2019 Third Quarter Results Canada NewsWire MISSISSAUGA, ON, Oct. 31, 2019 · Third Quarter Adjusted Total Revenue - $18.9 million and $55.1 million year-to-date · · Third Quarter Adjusted EBITD...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Research Inc Company Name:
NRIFF Stock Symbol:
OTCMKTS Market:
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...